COMMERCIAL MANUFACTURING AGREEMENTCommercial Manufacturing Agreement • August 8th, 2014 • Corcept Therapeutics Inc • Pharmaceutical preparations • Delaware
THIS MANUFACTURING AGREEMENT (the “Agreement”) is made and entered into this 7th day of April, 2014 (the “Effective Date”), by and between AAIPharma Services Corp., having a place of business at 2320 Scientific Park Drive, Wilmington, NC 28405 (“AAIPharma”) and Corcept Therapeutics Incorporated, having a place of business at 149 Commonwealth Drive, Menlo Park, CA 94025 (“Company”). AAIPharma and Company, as used herein, may be referred to, collectively, as “Parties” and individually as a “Party”.
SECOND AMENDMENT TO COMMERCIAL OUTSOURCING SERVICES AGREEMENTCommercial Outsourcing Services Agreement • August 8th, 2014 • Corcept Therapeutics Inc • Pharmaceutical preparations
This Second Amendment to the Commercial Outsourcing Services Agreement (this “Amendment”) is between Corcept Therapeutics, Inc. (the “Company”) and Integrated Commercialization Solutions, Inc. (“ICS”). This Amendment is effective as of June 11, 2014 (the “Amendment Effective Date”).
FIRST AMENDMENT TO COMMERCIAL OUTSOURCING SERVICES AGREEMENTCommercial Outsourcing Services Agreement • August 8th, 2014 • Corcept Therapeutics Inc • Pharmaceutical preparations
This First Amendment to the Commercial Outsourcing Services Agreement (this “Amendment”) is between Corcept Therapeutics, Inc. (the “Company”) and Integrated Commercialization Solutions, Inc. (“ICS”). This Amendment is effective as of April 14, 2014 (the “Amendment Effective Date”).
